Ectodysplasin Signaling through XEDAR Is Required for Mammary Gland Morphogenesis
Journal of Investigative Dermatology · 2023
DOI: 10.1016/j.jid.2023.02.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2023. Verfasst von Abigail R Wark und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Ectodysplasins, Membrane Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIAMS NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
XEDAR is a member of the TNF receptor subfamily and a mediator of the ectodysplasin (EDA) pathway. EDA signaling plays evolutionarily conserved roles in the development of the ectodermal appendage organ class, which includes hair, eccrine sweat glands, and mammary glands. Loss-of-function sequence variants of EDA, which encodes the two major ligand isoforms, EDA-A1 and EDA-A2, result in X-linked hypohidrotic ectodermal dysplasia characterized by defects in two or more types of ectodermal appendages. EDA-A1 and EDA-A2 signal through the receptors EDAR and XEDAR, respectively. Although the contributions of the EDA-A1/EDAR signaling pathway to EDA-dependent ectodermal appendage phenotypes have been extensively characterized, the significance of the EDA-A2/XEDAR branch of the pathway has remained obscure. In this study, we report the phenotypic consequences of disrupting the EDA-A2/XEDAR pathway on mammary gland differentiation and growth. Using a mouse Xedar knockout model, we show that Xedar has a specific and temporally restricted role in promoting late pubertal growth and branching of the mammary epithelium that can be influenced by genetic background. Our findings implicate Xedar in ectodermal appendage development and suggest that the EDA-A2/XEDAR signaling axis contributes to the etiology of EDA-dependent mammary phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: yana2@pennmedicine.upenn.edu.
Förderung
- NINDS NIH HHS
- NIAMS NIH HHS
- NICHD NIH HHS
- NIAID NIH HHS
- NIAMS
- Genentech
- NICHD
- Penn Skin Biology and Diseases Resource-based Center, University of Pennsylvania
Zitieren
APA
Wark, A. R., Aldea, D., Tomizawa, R. R., Kokalari, B., Warder, B., & Kamberov, Y. G. (2023). Ectodysplasin Signaling through XEDAR Is Required for Mammary Gland Morphogenesis. Journal of Investigative Dermatology. https://doi.org/10.1016/j.jid.2023.02.007
Vancouver
Wark AR, Aldea D, Tomizawa RR, Kokalari B, Warder B, Kamberov YG. Ectodysplasin Signaling through XEDAR Is Required for Mammary Gland Morphogenesis. Journal of Investigative Dermatology. 2023. doi:10.1016/j.jid.2023.02.007
BibTeX
@article{Wark2023,
author = {Wark, Abigail R and Aldea, Daniel and Tomizawa, Reiko R and Kokalari, Blerina and Warder, Bailey and Kamberov, Yana G},
title = {Ectodysplasin Signaling through XEDAR Is Required for Mammary Gland Morphogenesis},
journal = {Journal of Investigative Dermatology},
year = {2023},
doi = {10.1016/j.jid.2023.02.007}
}
EUVIMED